Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies

LANCET INFECTIOUS DISEASES

ELSEVIER SCI LTD

1. Japan Agency for Medical Research and Development (AMED) Research Program on Emerging and Re-emerging Infectious Diseases [JP22fk0108146, JP20fk0108413, JP20fk0108451]
2. AMED Research Program on HIV/AIDS [JP22fk0410039]
3. Japan Science and Technology Agency CREST programme [JPMJCR20H4]
4. Japan Society for the Promotion of Science (JSPS) Fund for the Promotion of Joint International Research (Fostering Joint International Research) [18KK0447]
5. JSPS Core-to-Core Program [JPJSCCA20190008]
6. Tokyo Biochemical Research Foundation
7. JSPS [DC2 22J11578]